Related references
Note: Only part of the references are listed.Pseudoprogression and hyperprogression after checkpoint blockade
Qiaohong Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Cancer: A disease at the crossroads of trade-offs
Camille Jacqueline et al.
EVOLUTIONARY APPLICATIONS (2017)
Spatial competition constrains resistance to targeted cancer therapy
Katarina Bacevic et al.
NATURE COMMUNICATIONS (2017)
Tuning cancer fate: the unremitting role of host immunity
B. Cali et al.
OPEN BIOLOGY (2017)
The importance of cancer cells for animal evolutionary ecology
Frederic Thomas et al.
NATURE ECOLOGY & EVOLUTION (2017)
Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State
Masoud H. Manjili
CANCER RESEARCH (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
Acquired resistance to immunotherapy and future challenges
Nicholas P. Restifo et al.
NATURE REVIEWS CANCER (2016)
The Evolution of Lifespan and Age-Dependent Cancer Risk
Andrii I. Rozhok et al.
TRENDS IN CANCER (2016)
Inclusive fitness effects can select for cancer suppression into old age
Joel S. Brown et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
The wound healing, chronic fibrosis, and cancer progression triad
Brad Rybinski et al.
PHYSIOLOGICAL GENOMICS (2014)
Positive and negative influence of the matrix architecture on antitumor immune surveillance
Elisa Peranzoni et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Preventive Evolutionary Medicine of Cancers
Michael E. Hochberg et al.
EVOLUTIONARY APPLICATIONS (2013)
Evolutionary foundations for cancer biology
C. Athena Aktipis et al.
EVOLUTIONARY APPLICATIONS (2013)
Life history trade-offs in cancer evolution
C. Athena Aktipis et al.
NATURE REVIEWS CANCER (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
Helene Salmon et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Evolutionary molecular medicine
Randolph M. Nesse et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Evolutionary medicine: its scope, interest and potential
Stephen C. Stearns
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Levi A. Garraway et al.
CANCER DISCOVERY (2012)
Evolved Tumor Suppression: Why Are We So Good at Not Getting Cancer?
James DeGregori
CANCER RESEARCH (2011)
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Brian F. Zamarron et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
Mina J. Bissell et al.
NATURE MEDICINE (2011)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms
Subhra K. Biswas et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Tolerance and cancer: Mechanisms of tumor evasion and strategies for breaking tolerance
MY Mapara et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Age-specific acceleration of cancer
SA Frank
CURRENT BIOLOGY (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Share Paper
